Gerhard Koenig, Jean-Francois Blain on Lessons from a failed γ-secretase Alzheimer trial.
COMMENT Bart De Strooper makes a passionate plea to continue exploring γ-secretase as a molecular target for Alzheimer’s disease. In general we agree with his assessment that γ-secretas e has received a bad reputation because of the failures of a few prominent ...